Palmitoylation of TNF alpha is involved in the regulation of TNF receptor 1 signalling

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 3, 2013, Pages 602-612

  Poggi, Marjorie ^a,b   Kara, Imène ^a,b   Brunel, Jean Michel ^c   Landrier, Jean François ^a,b   Govers, Roland ^a,b   Bonardo, Bernadette ^a,b   Fluhrer, Regina ^d,e   Haass, Christian ^d,e   Alessi, Marie Christine ^a,b   Peiretti, Franck ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d UNIVERSITY OF MUNICH   (Germany)

^e GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Lipid rafts; Palmitoylation; Signalling; TNF; TNFR1

Indexed keywords

CASPASE 8; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ACYLATION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; LIPID RAFT; MACROPHAGE; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ANIMALS; BLOTTING, WESTERN; CASPASE 8; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTERLEUKIN-6; LIPOYLATION; LUCIFERASES; MACROPHAGES; MEMBRANE MICRODOMAINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871874174     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.11.009     Document Type: Article

References (45)

1. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385:729-733.
2. Fluhrer R., Grammer G., Israel L., Condron M.M., Haffner C., Friedmann E., Bohland C., Imhof A., Martoglio B., Teplow D.B., Haass C. A gamma-secretase-like intramembrane cleavage of TNFalpha by the GxGD aspartyl protease SPPL2b. Nat. Cell Biol. 2006, 8:894-896.
3. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296:1634-1635.
4. Hsu H., Shu H.B., Pan M.G., Goeddel D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996, 84:299-308.
5. Muller S., Rihs S., Schneider J.M., Paredes B.E., Seibold I., Brunner T., Mueller C. Soluble TNF-alpha but not transmembrane TNF-alpha sensitizes T cells for enhanced activation-induced cell death. Eur. J. Immunol. 2009, 39:3171-3180.
6. Oikonomou N., Harokopos V., Zalevsky J., Valavanis C., Kotanidou A., Szymkowski D.E., Kollias G., Aidinis V. Soluble TNF mediates the transition from pulmonary inflammation to fibrosis. PLoS One 2006, 1:e108.
7. Rauert H., Wicovsky A., Muller N., Siegmund D., Spindler V., Waschke J., Kneitz C., Wajant H. Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2). J. Biol. Chem. 2010, 285:7394-7404.
8. Rajashekhar G., Grow M., Willuweit A., Patterson C.E., Clauss M. Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation. Physiol. Genomics 2007, 31:104-113.
9. Eissner G., Kolch W., Scheurich P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev. 2004, 15:353-366.
10. Zhang H., Yan D., Shi X., Liang H., Pang Y., Qin N., Chen H., Wang J., Yin B., Jiang X., Feng W., Zhang W., Zhou M., Li Z. Transmembrane TNF-alpha mediates "forward" and "reverse" signaling, inducing cell death or survival via the NF-kappaB pathway in Raji Burkitt lymphoma cells. J. Leukoc. Biol. 2008, 84:789-797.
11. Domonkos A., Udvardy A., Laszlo L., Nagy T., Duda E. Receptor-like properties of the 26kDa transmembrane form of TNF. Eur. Cytokine Netw. 2001, 12:411-419.
12. Friedmann E., Hauben E., Maylandt K., Schleeger S., Vreugde S., Lichtenthaler S.F., Kuhn P.H., Stauffer D., Rovelli G., Martoglio B. SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in activated dendritic cells to trigger IL-12 production. Nat. Cell Biol. 2006, 8:843-848.
13. Cottin V., Doan J.E., Riches D.W. Restricted localization of the TNF receptor CD120a to lipid rafts: a novel role for the death domain. J. Immunol. 2002, 168:4095-4102.
14. Legler D.F., Micheau O., Doucey M.A., Tschopp J., Bron C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 2003, 18:655-664.
15. Tellier E., Canault M., Rebsomen L., Bonardo B., Juhan-Vague I., Nalbone G., Peiretti F. The shedding activity of ADAM17 is sequestered in lipid rafts. Exp. Cell Res. 2006, 312:3969-3980.
16. Doan J.E., Windmiller D.A., Riches D.W. Differential regulation of TNF-R1 signaling: lipid raft dependency of p42mapk/erk2 activation, but not NF-kappaB activation. J. Immunol. 2004, 172:7654-7660.
17. Hunter I., Nixon G.F. Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells. Lipid rafts are essential for TNF-alpha-mediated activation of RhoA but dispensable for the activation of the NF-kappaB and MAPK pathways. J. Biol. Chem. 2006, 281:34705-34715.
18. Hueber A.O. Role of membrane microdomain rafts in TNFR-mediated signal transduction. Cell Death Differ. 2003, 10:7-9.
19. Muppidi J.R., Tschopp J., Siegel R.M. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 2004, 21:461-465.
20. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-39.
21. D'Alessio A., Kluger M.S., Li J.H., Al-Lamki R., Bradley J.R., Pober J.S. Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells. J. Biol. Chem. 2010, 285:23868-23879.
22. Schneider-Brachert W., Tchikov V., Neumeyer J., Jakob M., Winoto-Morbach S., Held-Feindt J., Heinrich M., Merkel O., Ehrenschwender M., Adam D., Mentlein R., Kabelitz D., Schutze S. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 2004, 21:415-428.
23. Kay J.G., Murray R.Z., Pagan J.K., Stow J.L. Cytokine secretion via cholesterol-rich lipid raft-associated SNAREs at the phagocytic cup. J. Biol. Chem. 2006, 281:11949-11954.
24. Zhang S., Liu T., Liang H., Zhang H., Yan D., Wang N., Jiang X., Feng W., Wang J., Li P., Li Z. Lipid rafts uncouple surface expression of transmembrane TNF-alpha from its cytotoxicity associated with ICAM-1 clustering in Raji cells. Mol. Immunol. 2009, 46:1551-1560.
25. Utsumi T., Takeshige T., Tanaka K., Takami K., Kira Y., Klostergaard J., Ishisaka R. Transmembrane TNF (pro-TNF) is palmitoylated. FEBS Lett. 2001, 500:1-6.
26. Peiretti F., Canault M., Deprez-Beauclair P., Berthet V., Bonardo B., Juhan-Vague I., Nalbone G. Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme. Exp. Cell Res. 2003, 285:278-285.
27. Martin L., Fluhrer R., Reiss K., Kremmer E., Saftig P., Haass C. Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b. J. Biol. Chem. 2008, 283:1644-1652.
28. Bernot D., Barruet E., Poggi M., Bonardo B., Alessi M.C., Peiretti F. Down-regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) expression is necessary for adipocyte differentiation. J. Biol. Chem. 2010, 285:6508-6514.
29. Bernot D., Stalin J., Stocker P., Bonardo B., Scroyen I., Alessi M.C., Peiretti F. Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase. J. Cell Sci. 2011, 124:1224-1230.
30. Canault M., Leroyer A.S., Peiretti F., Leseche G., Tedgui A., Bonardo B., Alessi M.C., Boulanger C.M., Nalbone G. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. Am. J. Pathol. 2007, 171:1713-1723.
31. Fluhrer R., Fukumori A., Martin L., Grammer G., Haug-Kroper M., Klier B., Winkler E., Kremmer E., Condron M.M., Teplow D.B., Steiner H., Haass C. Intramembrane proteolysis of GXGD-type aspartyl proteases is slowed by a familial Alzheimer disease-like mutation. J. Biol. Chem. 2008, 283:30121-30128.
32. Martin B.R., Cravatt B.F. Large-scale profiling of protein palmitoylation in mammalian cells. Nat. Methods 2009, 6:135-138.
33. Nyborg A.C., Ladd T.B., Jansen K., Kukar T., Golde T.E. Intramembrane proteolytic cleavage by human signal peptide peptidase like 3 and malaria signal peptide peptidase. FASEB J. 2006, 20:1671-1679.
34. Turner N.A., Mughal R.S., Warburton P., O'Regan D.J., Ball S.G., Porter K.E. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. Cardiovasc. Res. 2007, 76:81-90.
35. Jupp O.J., McFarlane S.M., Anderson H.M., Littlejohn A.F., Mohamed A.A., MacKay R.H., Vandenabeele P., MacEwan D.J. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways. Biochem. J. 2001, 359:525-535.
36. Lewis M., Tartaglia L.A., Lee A., Bennett G.L., Rice G.C., Wong G.H., Chen E.Y., Goeddel D.V. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:2830-2834.
37. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
38. Juo P., Kuo C.J., Yuan J., Blenis J. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr. Biol. 1998, 8:1001-1008.
39. Levental I., Lingwood D., Grzybek M., Coskun U., Simons K. Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:22050-22054.
40. Boutet P., Aguera-Gonzalez S., Atkinson S., Pennington C.J., Edwards D.R., Murphy G., Reyburn H.T., Vales-Gomez M. Cutting edge: the metalloproteinase ADAM17/TNFα-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein. J. Immunol. 2009, 182:49-53.
41. Stoeck A., Shang L., Dempsey P.J. Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth. J. Cell Sci. 2010, 123:2319-2331.
42. D'Alessio A., Al-Lamki R.S., Bradley J.R., Pober J.S. Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line. Am. J. Pathol. 2005, 166:1273-1282.
43. Decoster E., Vanhaesebroeck B., Boone E., Plaisance S., De Vos K., Haegeman G., Grooten J., Fiers W. Induction of unresponsiveness to tumor necrosis factor (TNF) after autocrine TNF expression requires TNF membrane retention. J. Biol. Chem. 1998, 273:3271-3277.
44. Haas E., Grell M., Wajant H., Scheurich P. Continuous autotropic signaling by membrane-expressed tumor necrosis factor. J. Biol. Chem. 1999, 274:18107-18112.
45. Rossin A., Derouet M., Abdel-Sater F., Hueber A.O. Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling. Biochem. J. 2009, 419:185-192. (182 p following 192).